Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Expecting enough bird flu vaccine for everyone is a big ask

According to researchers an experimental vaccine produced to offer protection against the H5N1 strain of bird flu presently causing havoc across the world, only appears to work at the very highest doses.

31 Mar 2006

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

30 Mar 2006

Custom made nanoparticles will transform cancer diagnosis and treatment

Researchers have developed "custom" nanoparticles that promise to provide a more targeted and effective way of delivering anticancer drugs than conventional medications or any of the earlier attempts to fight cancer with nanoparticles.

28 Mar 2006

Researchers find environmentally friendly ways to produce more Taxol

As the effective cancer-treatment drug Taxol enters its next generation, Michigan State University announces discoveries which point to both environmentally friendly ways to produce more Taxol, and ultimately innovations to produce a more potent second-generation drug.

28 Mar 2006

Artificial bone generated by computer

This technology takes its lead from nature: Bones are masterpieces of lightweight construction that can withstand immense stresses.

23 Mar 2006

Study first to document cumulative effect of racial, sexual harrassment

New research at the University of Toronto is the first to empirically document that women who are visible minorities face a double dose of harassment in the workplace, based on both sex and ethnicity.

23 Mar 2006

U.S. screening for highly pathogenic H5N1 avian influenza in migratory birds

Secretary of Agriculture Mike Johanns, Secretary of the Interior Gale A. Norton and Secretary of Health and Human Services Michael Leavitt have moved to further ensure the protection of people, domestic poultry and wild birds by unveiling an enhanced national framework for early detection of highly pathogenic avian influenza (HPAI) in wild migratory birds in the United States.

21 Mar 2006

Lives in danger as drug trial goes horribly wrong

In a drug trial which went horribly wrong two men are critically ill in a London hospital and four others are seriously ill, after suffering violent reactions to a new drug they took as part of a clinical trial.

16 Mar 2006

New agreement on Chinese malaria vaccine candidate

In a move that promises to expand the clinical testing of another promising malaria vaccine candidate, the US-based PATH Malaria Vaccine Initiative (MVI) and the Chinese company Shanghai Wanxing Bio-Pharmaceuticals today announced an agreement that supports the development of a pediatric malaria vaccine against Plasmodium (P.) falciparum, the most deadly strain of malaria.

15 Mar 2006

HemoCue wins patent infringement suit

For more than two years, HemoCue AB and EKF-diagnostics GmbH, a company in Magdeburg, Germany, have been involved in a patent infringement suit.

14 Mar 2006

Novavax and Bharat Biotech form alliance for influenza vaccine development

Novavax and Bharat Biotech International Limited (BBIL), have jointly announced a strategic alliance to pursue the rapid development of pandemic influenza vaccine for India and certain other south Asian markets.

7 Mar 2006

New Australian bird flu research

University of Queensland researchers will lead two projects announced as part of the Commonwealth Government's $6.5 million bird flu research program.

23 Feb 2006

Women from Venus love chocolate from Mars

CocoaVia the long-awaited chocolate from confectionery giant Mars is about to hit the market.

22 Feb 2006

Ebola DNA vaccine shows promise

Vical Incorporated has announced that an Ebola vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated, and produced both antibody and T-cell Ebola-specific responses in all healthy volunteers who received the full 3 doses of vaccine.

21 Feb 2006

New flu vaccine takes weeks to mass produce

Using cell-based methods researchers have developed a commercially viable method for mass producing effective vaccines against potential pandemic influenza strains in weeks instead of the months required for traditional egg-based vaccines.

17 Feb 2006

New FDA report says earlier meetings w/FDA make drug review process more efficient

The FDA has released a new report that takes carefully examines the way the agency reviews applications for drugs and biologics that have not previously been approved by the FDA.

16 Feb 2006

Ice-templated fabrication shows promise for artificial bone

The next generation of artificial bone may rely on a few secrets from the sea. Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have harnessed the way seawater freezes to develop a porous, scaffolding-like material that is four times stronger than material currently used in synthetic bone.

7 Feb 2006